ASEAN strikes IP agreements with China and Europe
This article was originally published in Scrip
The Association of Southeast Asian Nations (ASEAN) has reached new agreements with China and the European Commission (EC) on intellectual property, which, although general in scope, will influence activities in the pharma sector.
You may also be interested in...
While disappointing result will probably put an end to single-drug plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.
Japanese firm in discussions with regulator as high-need novel therapy for spinocerebellar degeneration misses endpoint but shows promise in pooled analysis.